Aclarion announced it has established a commercial agreement with Sheridan Community Hospital in Sheridan, Michigan. The agreement brings Nociscan to central Michigan and leading neurosurgeon, John Keller, MD. “At Sheridan Community Hospital, we are committed to bringing dedication and expertise to provide individual-based professional health care for the families in our community – and beyond,” says Lili Petricevic, CEO of Sheridan Community Hospital. “We are thrilled to engage with Aclarion and bring their innovative solution, Nociscan, to our community. Low back pain affects our community and Nociscan will be a valuable decision support tool when choosing treatment options.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACON:
- Aclarion Announces First Commercial Agreement in Michigan
- Aclarion Hits Another Key Milestone by Adding Vitality – Third Major Payer to Cover Nociscan in Greater UK
- Aclarion initiated with a Buy at Ascendiant
- Aclarion announced key milestone with their second payer coverage of Nociscan
- Aclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UK